A detailed history of Amalgamated Bank transactions in Myriad Genetics Inc stock. As of the latest transaction made, Amalgamated Bank holds 26,656 shares of MYGN stock, worth $363,854. This represents 0.01% of its overall portfolio holdings.

Number of Shares
26,656
Previous 27,421 2.79%
Holding current value
$363,854
Previous $671,000 8.79%
% of portfolio
0.01%
Previous 0.01%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$23.97 - $28.6 $18,337 - $21,879
-765 Reduced 2.79%
26,656 $730,000
Q2 2024

Aug 12, 2024

SELL
$17.98 - $25.47 $14,761 - $20,910
-821 Reduced 2.91%
27,421 $671,000
Q1 2024

Apr 23, 2024

SELL
$17.59 - $23.59 $72,418 - $97,120
-4,117 Reduced 12.72%
28,242 $602,000
Q4 2023

Feb 06, 2024

BUY
$13.91 - $21.32 $9,625 - $14,753
692 Added 2.19%
32,359 $619,000
Q3 2023

Nov 08, 2023

SELL
$15.99 - $23.22 $15,398 - $22,360
-963 Reduced 2.95%
31,667 $508,000
Q2 2023

Aug 11, 2023

SELL
$17.56 - $23.76 $22,371 - $30,270
-1,274 Reduced 3.76%
32,630 $756,000
Q1 2023

May 02, 2023

SELL
$15.26 - $23.75 $41,400 - $64,433
-2,713 Reduced 7.41%
33,904 $788,000
Q4 2022

Feb 10, 2023

BUY
$14.51 - $20.99 $4,106 - $5,940
283 Added 0.78%
36,617 $531,000
Q3 2022

Nov 09, 2022

BUY
$18.21 - $27.88 $6,227 - $9,534
342 Added 0.95%
36,334 $693,000
Q2 2022

Aug 15, 2022

BUY
$16.45 - $25.88 $4,063 - $6,392
247 Added 0.69%
35,992 $654,000
Q1 2022

Jun 30, 2022

SELL
$22.67 - $28.01 $38,652 - $47,757
-1,705 Reduced 4.55%
35,745 $901,000
Q4 2021

Feb 15, 2022

BUY
$24.13 - $32.63 $5,163 - $6,982
214 Added 0.57%
37,450 $1.03 Million
Q3 2021

Oct 29, 2021

SELL
$29.97 - $36.66 $18,371 - $22,472
-613 Reduced 1.62%
37,236 $1.2 Million
Q2 2021

Aug 16, 2021

BUY
$25.39 - $32.61 $960,986 - $1.23 Million
37,849 New
37,849 $1.16 Million
Q2 2020

Aug 10, 2020

SELL
$10.69 - $16.49 $125,885 - $194,186
-11,776 Closed
0 $0
Q1 2020

May 13, 2020

SELL
$9.78 - $29.53 $2,484 - $7,500
-254 Reduced 2.11%
11,776 $169,000
Q4 2019

Feb 13, 2020

BUY
$20.93 - $35.1 $19,130 - $32,081
914 Added 8.22%
12,030 $328,000
Q3 2019

Nov 13, 2019

SELL
$22.08 - $47.08 $5,453 - $11,628
-247 Reduced 2.17%
11,116 $318,000
Q2 2019

Aug 14, 2019

BUY
$22.67 - $35.0 $13,987 - $21,595
617 Added 5.74%
11,363 $316,000
Q1 2019

May 15, 2019

BUY
$26.93 - $34.7 $9,210 - $11,867
342 Added 3.29%
10,746 $357,000
Q4 2018

Feb 15, 2019

BUY
$27.23 - $45.56 $142,331 - $238,142
5,227 Added 100.97%
10,404 $302,000
Q3 2018

Nov 14, 2018

SELL
$37.57 - $50.34 $204,155 - $273,547
-5,434 Reduced 51.21%
5,177 $238,000
Q2 2018

Jul 18, 2018

BUY
$27.75 - $40.17 $36,130 - $52,301
1,302 Added 13.99%
10,611 $397,000
Q1 2018

May 22, 2018

SELL
$28.83 - $41.01 $4,180 - $5,946
-145 Reduced 1.53%
9,309 $275,000
Q4 2017

Feb 13, 2018

BUY
$28.45 - $37.14 $21,934 - $28,634
771 Added 8.88%
9,454 $325,000
Q3 2017

Nov 09, 2017

BUY
$24.01 - $36.2 $208,478 - $314,324
8,683
8,683 $314,000

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.1B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.